Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/179150
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarola, Giulia-
dc.contributor.authorMalagarriga, Daniel-
dc.contributor.authorCalatayud Aristoy, Carles-
dc.contributor.authorPons-Espinal, Meritxell-
dc.contributor.authorBlasco Agell, Lucas-
dc.contributor.authorRichaud-Patin, Yvonne-
dc.contributor.authorFernandez-Carasa, Irene-
dc.contributor.authorBaruffi, Valentina-
dc.contributor.authorBeltramone, Silvia-
dc.contributor.authorMolina, Elsa-
dc.contributor.authorDell’Era, Patrizia-
dc.contributor.authorToledo Aral, Juan J.-
dc.contributor.authorTolosa, Eduardo-
dc.contributor.authorMuotri, Alysson R.-
dc.contributor.authorGarcia Ojalvo, Jordi-
dc.contributor.authorSoriano i Fradera, Jordi-
dc.contributor.authorRaya Chamorro, Ángel-
dc.contributor.authorConsiglio, Antonella-
dc.date.accessioned2021-07-19T08:21:12Z-
dc.date.available2021-07-19T08:21:12Z-
dc.date.issued2021-07-02-
dc.identifier.issn2373-8057-
dc.identifier.urihttp://hdl.handle.net/2445/179150-
dc.description.abstractA deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients' networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSpringer-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41531-021-00198-3-
dc.relation.ispartofnpj Parkinson's Disease, 2021, vol. 7, num. 55-
dc.relation.urihttps://doi.org/10.1038/s41531-021-00198-3-
dc.rightscc by (c) Carola, Giulia et al., 2021-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subject.classificationMalaltia de Parkinson-
dc.subject.classificationMutació (Biologia)-
dc.subject.classificationEnginyeria genètica-
dc.subject.otherParkinson's disease-
dc.subject.otherMutation (Biology)-
dc.subject.otherGenetic engineering-
dc.titleParkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec707718-
dc.date.updated2021-07-16T07:19:47Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Institut de Recerca en Sistemes Complexos (UBICS))
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Física de la Matèria Condensada)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Files in This Item:
File Description SizeFormat 
s41531-021-00198-3.pdf8.03 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons